Status:
ACTIVE_NOT_RECRUITING
Study of Placental Inflammation in Gestational Diabetes
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Gestational Diabetes Mellitus (GDM)
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate the placental inflammation in women with gestational diabetes mellitus, in particular the role of inflammasome NLRP3 and the chemokine scavenger decoy receptor ...
Detailed Description
The aim of this study is to investigate systemic and placental inflammation in women with gestational diabetes mellitus, in particular the role of inflammasome NLRP3 and the chemokine scavenger decoy ...
Eligibility Criteria
Inclusion
- Women with gestational diabetes mellitus
- Women with uncomplicated pregnancy
- Age \>18 years
- Singleton pregnancy
Exclusion
- Age \< 18 years
- Infections (HIV,HCV)
- Multiple pregnancy
- Cancer
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06884696
Start Date
July 1 2022
End Date
June 30 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli
Rome, Italy, 00168